Study on Network Pharmacology of Jiuwei Zhenxin Granules in the Treatment of Bipolar Disorder
Open Access
- 23 August 2024
- conference paper
- Published by Association for Computing Machinery (ACM)
- p. 103-110
Abstract
In this study, we inquired about the composition and efficacy of Jiuwei Zhenxin Granules, searched for relevant information using databases, obtained the action targets through TCMSP database and scored them, screened the bipolar disorder related targets in OMIM database, and finally constructed the target network by using String and Cytoscape, imported into Metascape, performed the KEGG analysis and visualization. The results showed that the key genes of bipolar disorder were CSRNP3, PIK3R1, RNF115, NRIP3, KIF3A, DYNC1LI1, PCMT1, CHL1, SLC25A32, SEH1L, COPS4, ARVCF, EPN1, RTEL1, PTOV1-AS2, GUCA2A, EPHB4. We also mined each active ingredient of Jiuwei Zhenxin Granule and constructed a network for further enrichment and elaboration, and obtained the key targets CASP3, PTGS2, PPARG, NOS3, and the key pharmacological active ingredient J1 (Stigmasterol), J6 (Quercetin) explaining the molecular mechanism of Jiuwei Zhenxin Granule in the treatment of bipolar affective disorders.Keywords
This publication has 3 references indexed in Scilit:
- CASP3 gene expression and the role of caspase 3 in the pathogenesis of depressive disordersBMC Psychiatry, 2023
- Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-AnalysisInternational Journal of Molecular Sciences, 2022
- The evaluation of both the expression and serum protein levels of Caspase‐3 gene in patients with different degrees of SARS‐CoV2 infectionJournal of Medical Virology, 2021